Frank Stenner-Liewen
Rational use of immunoglobulins (IVIgs and SCIgs) in secondary antibody deficiencies.
Goede J, Baumann C, Cathomas R, Khanna N, Lambert J, Lehmann T, Mey U, Seebach J, Steiner U, Tschan-Plessl A, Stenner-Liewen F. Rational use of immunoglobulins (IVIgs and SCIgs) in secondary antibody deficiencies. Swiss Med Wkly 2024; 154:3559.
Sep 9, 2024Rational use of immunoglobulins (IVIgs and SCIgs) in secondary antibody deficiencies.
Sep 9, 2024Swiss Med Wkly 2024; 154:3559
Goede Jeroen, Baumann Christa K, Cathomas Richard, Khanna Nina, Lambert Jean-Francois, Lehmann Thomas, Mey Ulrich J M, Seebach Jörg, Steiner U C, Tschan-Plessl Astrid, Stenner-Liewen Frank
Early response monitoring during [Lu]Lu-PSMA I&T therapy with quantitated SPECT/CT predicts overall survival of mCRPC patients: subgroup analysis of a Swiss-wide prospective registry study.
Neubauer M, Nicolas G, Bauman A, Fani M, Nitzsche E, Afshar-Oromieh A, Forrer F, Rentsch C, Stenner-Liewen F, Templeton A, Schäfer N, Wild D, Chirindel A, all investigators on behalf of the SSNM Therapy Working Group. Early response monitoring during [Lu]Lu-PSMA I&T therapy with quantitated SPECT/CT predicts overall survival of mCRPC patients: subgroup analysis of a Swiss-wide prospective registry study. Eur J Nucl Med Mol Imaging 2023
Dec 1, 2023Early response monitoring during [Lu]Lu-PSMA I&T therapy with quantitated SPECT/CT predicts overall survival of mCRPC patients: subgroup analysis of a Swiss-wide prospective registry study.
Dec 1, 2023Eur J Nucl Med Mol Imaging 2023
Neubauer Moritz C, Nicolas Guillaume, Bauman Andreas, Fani Melpomeni, Nitzsche Egbert U, Afshar-Oromieh Ali, Forrer Flavio, Rentsch Cyrill A, Stenner-Liewen Frank, Templeton Arnoud J, Schäfer Niklaus G, Wild Damian, Chirindel Alin, all investigators on behalf of the SSNM Therapy Working Group
Interdisciplinary Swiss consensus recommendations on staging and treatment of advanced prostate cancer.
Templeton A, Omlin A, Berthold D, Beyer J, Burger I, Eberli D, Engeler D, Fankhauser C, Fischer S, Gillessen S, Nicolas G, Kroeze S, Lorch A, Müntener M, Papachristofilou A, Schäfer N, Seiler D, Stenner-Liewen F, Tsantoulis P, Vlajnic T, Zilli T, Zwahlen D, Cathomas R. Interdisciplinary Swiss consensus recommendations on staging and treatment of advanced prostate cancer. Swiss Med Wkly 2023; 153:40108.
Aug 15, 2023Interdisciplinary Swiss consensus recommendations on staging and treatment of advanced prostate cancer.
Aug 15, 2023Swiss Med Wkly 2023; 153:40108
Templeton Arnoud J, Omlin Aurelius, Berthold Dominik R, Beyer Jörg, Burger Irene A, Eberli Daniel, Engeler Daniel, Fankhauser Christian Daniel, Fischer Stefanie, Gillessen Silke, Nicolas Guillaume, Kroeze Stephanie G C, Lorch Anja, Müntener Michael, Papachristofilou Alexandros, Schäfer Niklaus G, Seiler Daniel, Stenner-Liewen Frank, Tsantoulis Petros, Vlajnic Tatjana, Zilli Thomas, Zwahlen Daniel Rudolf, Cathomas Richard
Prognostic factors for survival in lymphoma patients after autologous stem cell transplantation
Samaras P, Renner C, Stahel R, Knuth A, Taverna C, Schäfer N, Mischo A, Schanz U, Siciliano R, Honegger H, Haile S, Buset E, Petrausch U, Zardavas D, Stenner-Liewen F. Prognostic factors for survival in lymphoma patients after autologous stem cell transplantation. Swiss Med Wkly 2013; 143:w13791.
May 7, 2013Prognostic factors for survival in lymphoma patients after autologous stem cell transplantation
May 7, 2013Swiss Med Wkly 2013; 143:w13791
Samaras Panagiotis, Renner Christoph, Stahel Rolf, Knuth Alexander, Taverna Christian, Schäfer Niklaus G, Mischo Axel, Schanz Urs, Siciliano Raffaele D, Honegger Hanspeter, Haile Sarah, Buset Elefteri M, Petrausch Ulf, Zardavas Dimitrios, Stenner-Liewen Frank
Validation of prognostic factors and survival of patients with multiple myeloma in a real-life autologous stem cell transplantation setting: a Swiss single centre experience
Samaras P, Stenner-Liewen F, Knuth A, Bauer S, Taverna C, Stussi G, Schanz U, Honegger H, Zweifel M, Mischo A, Petrausch U, Siciliano R, Haile S, Blickenstorfer M, Renner C. Validation of prognostic factors and survival of patients with multiple myeloma in a real-life autologous stem cell transplantation setting: a Swiss single centre experience. Swiss Med Wkly 2011; 141:w13203.
May 31, 2011Validation of prognostic factors and survival of patients with multiple myeloma in a real-life autologous stem cell transplantation setting: a Swiss single centre experience
May 31, 2011Swiss Med Wkly 2011; 141:w13203
Samaras Panagiotis, Stenner-Liewen Frank, Knuth Alexander, Bauer Stefan, Taverna Christian, Stussi Georg, Schanz Urs, Honegger Hanspeter, Zweifel Martin, Mischo Axel, Petrausch Ulf, Siciliano Raffaele Daniele, Haile Sarah, Blickenstorfer Marcel, Renner Christoph
Equivalence of Pegfilgrastim and Filgrastim in Lymphoma Patients Treated with BEAM Followed by Autologous Stem Cell Transplantation
Samaras P, Renner C, Knuth A, Stahel R, Stussi G, Schanz U, Pestalozzi B, Honegger H, Mischo A, Petrausch U, Haile S, Siciliano R, Buset E, Stenner-Liewen F. Equivalence of Pegfilgrastim and Filgrastim in Lymphoma Patients Treated with BEAM Followed by Autologous Stem Cell Transplantation. Oncology 2010; 79:93-97.
Nov 15, 2010Equivalence of Pegfilgrastim and Filgrastim in Lymphoma Patients Treated with BEAM Followed by Autologous Stem Cell Transplantation
Nov 15, 2010Oncology 2010; 79:93-97
Samaras Panagiotis, Renner Christoph, Knuth Alexander, Stahel Rolf A, Stussi Georg, Schanz Urs, Pestalozzi Bernhard C, Honegger Hanspeter, Mischo Axel, Petrausch Ulf, Haile Sarah, Siciliano Raffaele Daniele, Buset Elefteri M, Stenner-Liewen Frank
Pegfilgrastim reduces the length of hospitalization and the time to engraftment in multiple myeloma patients treated with melphalan 200 and auto-SCT compared with filgrastim
Samaras P, Stenner-Liewen F, Knuth A, Stahel R, Stussi G, Schanz U, Honegger H, Mischo A, Petrausch U, Buset E, Haile S, Siciliano R, Blickenstorfer M, Renner C. Pegfilgrastim reduces the length of hospitalization and the time to engraftment in multiple myeloma patients treated with melphalan 200 and auto-SCT compared with filgrastim. Ann Hematol 2010; 90:89-94.
Aug 13, 2010Pegfilgrastim reduces the length of hospitalization and the time to engraftment in multiple myeloma patients treated with melphalan 200 and auto-SCT compared with filgrastim
Aug 13, 2010Ann Hematol 2010; 90:89-94
Samaras Panagiotis, Stenner-Liewen Frank, Knuth Alexander, Stahel Rolf A, Stussi Georg, Schanz Urs, Honegger Hanspeter, Mischo Axel, Petrausch Ulf, Buset Elefteri M, Haile Sarah, Siciliano Raffaele Daniele, Blickenstorfer Marcel, Renner Christoph
Concomitant statin use does not impair the clinical outcome of patients with diffuse large B cell lymphoma treated with rituximab-CHOP
Samaras P, Stenner-Liewen F, Knuth A, Zweifel M, Mischo A, Meisel A, Siciliano R, Schaefer N, Petrausch U, Haile S, Heider H, Renner C. Concomitant statin use does not impair the clinical outcome of patients with diffuse large B cell lymphoma treated with rituximab-CHOP. Ann Hematol 2010; 89:783-7.
Mar 5, 2010Concomitant statin use does not impair the clinical outcome of patients with diffuse large B cell lymphoma treated with rituximab-CHOP
Mar 5, 2010Ann Hematol 2010; 89:783-7
Samaras Panagiotis, Stenner-Liewen Frank, Knuth Alexander, Zweifel Martin, Mischo Axel, Meisel Alexander, Siciliano Raffaele Daniele, Schaefer Niklaus G, Petrausch Ulf, Haile Sarah, Heider Helen, Renner Christoph